Mesothelioma: Benefit from surgical resection is questionable

Journal of Thoracic Oncology

Volumn 2, Issue 10, 2007, Pages 885-886

  Treasure, Tom ^a   Utley, Martin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ASBESTOSIS; CANCER PAIN; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; EDITORIAL; HUMAN; LUNG RESECTION; MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; SURVIVAL TIME;

HUMANS; MESOTHELIOMA; TREATMENT OUTCOME;

EID: 34848857664     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318156af3b     Document Type: Editorial

References (6)

1. Flores R, et al. Prognostic factors in the treatment of malignant pleural mesothelioma (MPM) at a large tertiary referral centre. J Thorac Oncol. 2007;2:957-965.
2. Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004 Jul;128:138-146.
3. Treasure T. The evidence on which to base practice: Different tools for different times. Eur J Cardiothorac Surg. 2006 Dec;30:819-824.
4. Treasure T, Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg. 2007 Jun; 133:1414-1418.
5. Treasure T, Tan C, Lang-Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact CardioVasc Thorac Surg. 2006;5:58-59.
6. Rusch VW. Thoracic surgical clinical trials: Y2K and beyond. Ann Thorac Surg. 1999 Jul;68:2-3.